Daniel B Horne

Years Active: 2018-2018
Publications (10 Years): 1

SAGE Therapeutics Inc

This page only lists publications with an associated author ORCID identifier.

Affiliation History

SAGE Therapeutics Inc May 10 2018

United States

Principal Scientist :: Research

Amgen Inc Mar 15 2006 - May 07 2018

United States

Principal Scientist :: Medicinal Chemistry

Publications

Daniel B Horne, Kaustav Biswas, James Brown, Michael D Bartberger, Jeffrey Clarine, Carl D Davis, Vijay K Gore, Scott Harried, Michelle Horner, Matthew R Kaller, Sonya G Lehto, Qingyian Liu, Vu V Ma, Holger Monenschein, Thomas T Nguyen, Chester C Yuan, Beth D Youngblood, Maosheng Zhang, Wenge Zhong, Jennifer R Allen, Jian Jeffrey Chen, Narender R Gavva
Discovery of TRPM8 Antagonist ( S)-6-(((3-Fluoro-4-(trifluoromethoxy)phenyl)(3-fluoropyridin-2-yl)methyl)carbamoyl)nicotinic Acid (AMG 333), a Clinical Candidate for the Treatment of Migraine. Journal of medicinal chemistry 61 (18) (2018)

Daniel B Horne.css-eqlu8i{font-size:small;padding-left:4px;}